Newborn and Infant Nursing Reviews
Volume 6, Issue 4 , Pages 193-201 , December 2006

Neonatal Infusion Therapy: Preventing Complications and Improving Outcomes

  • Sandy Sundquist Beauman, MSN, RNC

      Affiliations

    • Corresponding Author InformationAddress correspondences to Sandy Sundquist Beauman, MSN, RNC, Neonatal Clinical Nurse Specialist, Huntington Memorial Hospital, Pasadena, CA, CNS Consulting, PO Box 77848, Corona, CA, 92877.
    • ,
  • Anne Swanson, MSN, RNC

References 

  1. Pettit J. Assessment of the infant with a peripheral intravenous device. Adv Neonatal Care. 2003;3:230–240
  2. Pettit J, Wycoff MM. Peripherally inserted central catheters: guideline for practice. Document 1221. Glenview, IL: The National Association of Neonatal Nurses; 2001;
  3. Pettit J, Hughes K. Intravenous extravasation: mechanisms, management, and prevention. J Perinat, Neonatal Nursing. 1993;6:69–79
  4. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2006;29(Suppl 1):S1–S90
  5. Centers for Disease Control and Prevention: guidelines for the prevention of intravascular catheter-related infections. MWWR Morb Mortal Wkly Rep. 2002;51:1–30
  6. Rosse C, Gaddum-Rosse P. Hollinshead's textbook of anatomy. Philadelphia, PA: Lippincott-Raven; 1997;
  7. Association of Women's Health, Obstetric and Neonatal Nurses . Evidence based clinical practice guideline: neonatal skin care. Washington, DC: Association of Women's Health, Obstetric and Neonatal Nurses; 2001;
  8. Kuller JM, Lund C, Nonato LB. Neonatal integumentary system. Columbus, OH: Ross Pediatrics; 1999;
  9. Lininger RA. Pediatric peripheral IV insertion success rates. J Pediatr Nurs. 2003;29:351–354
  10. Franck LS, Hummel D, Connell K, et al. The safety and efficacy of peripheral intravenous catheters in ill neonates. Neonatal Netw. 2001;20:33–38
  11. Frey AM. Success rates for peripheral IV insertion in a children's hospital: financial implications. J Intraven Nurs. 1998;21:160–165
  12. Stevens B, Gibbins S, Franck LS. Treatment of pain in the neonatal intensive care unit. Pediatr Clin North Am. 2000;47:633–650
  13. Duhn LJ, Medves JM. A systematic integrative review of infant pain assessment tools. Adv Neonatal Care. 2004;4:126–140
  14. Occupational Safety & Health Administration: Regulations (Standards—29CFR) Bloodborne pathogens—1910.1030. Retrieved on 5/28/06—http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051.
  15. Benis MM. Efficacy of sucrose as analgesia for procedural pain in neonates. Adv Neonatal Care. 2002;2:93–100
  16. Prince WL, Horns KM, Latta TM, et al. Treatment of neonatal pain without a gold standard: the case for caregiving interventions and sucrose administration. Neonatal Netw. 2004;23:33–45
  17. Darmstadt GL, Dinulos JG. Neonatal skin care. Pediatr Clin North Am. 2000;47:757–782
  18. Reynolds PR, Banerjee S, Meek JH. Alcohol burns in extremely low birthweight infants: still occurring. Arch Dis Child, Fetal, Neonatal Ed. 2005;90:F10
  19. Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J. 1995;14:510–516
  20. Khashu M, Chessex P, Chanoine JP. Iodine overload and severe hypothyroidism in a premature neonate. J Pediatr Surg. 2005;40:E1–E4
  21. Linder N, Sela B, German B, et al. Iodine and hypothyroidism in neonates with congenital heart disease. Arch Dis Child Fetal Neonatal Ed. 1997;77:F239–F240
  22. Parravicini E, Fontana C, Paterlini GL, et al. Iodine, thyroid function, and very low birth weight infants. Pediatrics. 1996;98:730
  23. Linder N, Prince S, Barzilai A, et al. Disinfection with 10% povidone-iodine versus 0.5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit. Acta Paediatrica. 2004;93:205–210
  24. Malathi I, Millar MR, Leeming JP, et al. Skin disinfection in preterm infants. Arch Dis Child. 1993;69:312–316
  25. National Association of Neonatal Nurses. Position statement on latex allergy, #3016a. Glenview, IL: National Association of Neonatal Nurses; 2003;
  26. United States Food and Drug Administration: (July 12,2002). FDA public health notification: PVC devices containing the D.E.HP. plasticizer, 2002. Retrieved 5/28/06 from http://www.fda.gov/cdrh/safety/dehp.html.
  27. Redelmeier D, Livesley NJ. Adhesive tape and intravascular-catheter associated infections. J Gen Intern Med. 1999;14:373
  28. James MJ, Lasker BA, McNeil MM, et al. Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in a neonatal intensive care unit. J Clin Microbiol. 2000;38:3612–3618
  29. Wright A. Reducing infusion failure: a pharmacologic approach—a review. J Intraven Nurs. 1996;19:89–97
  30. Perdue MB. Intravenous complications. In:  Hankins J,  Lonsway RA,  Hedrick C,  Perdue MB editor. Infusion therapy in clinical practice. 2nd ed. St Louis, MO: Saunders; 2001;p. 418–445
  31. Zenk KE, Sills JH, Koeppel RM. Neonatal medications & nutrition: a comprehensive guide. 3rd ed. Santa Rosa, CA: NICU Ink; 2003;
  32. Kuwahara T, Asanami S, Kubo S. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition. 1998;14:496–501
  33. Wycoff MM, McGrath JM, Griffin T, Malan J, White-Traut R. Nutrition: physiologic basis of metabolism and management of enteral and parenteral nutrition. In:  Kenner C,  Lott JW editor. Comprehensive neonatal nursing: a physiologic perspective. 3rd ed. Philadelphia, PA: Saunders; 2003;p. 425–447
  34. Vesely TM, Stranz M, Masoorli S, Hadaway LC. The diverse and conflicting standards and practices in infusion therapy. J Vasc Access Devices. 2002;7:9–25
  35. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med. 1991;114:845–854
  36. Lund CH, Kuller JM. Assessment and management of the integumentary system. In:  Kenner C,  Lott JW editor. Comprehensive neonatal nursing: a physiologic perspective. 3rd ed. Philadelphia, PA: Saunders; 2003;p. 700–724
  37. Hecker JF. Potential for extending survival of peripheral intravenous infusions. Br J Med. 1992;304:619–624
  38. Hecker JF, Fisk GC, Lewis GB. Phlebitis and extravasation (“tissuing”) with intravenous infusions. Med J Aust. 1984;140:650–658
  39. Wilson D. Starting neonatal IVs: practical tips. Mother J Baby. 2000;5:11–19

PII: S1527-3369(06)00098-5

doi: 10.1053/j.nainr.2006.09.001

Newborn and Infant Nursing Reviews
Volume 6, Issue 4 , Pages 193-201 , December 2006

Article Tools

* Image Usage & Resolution